Physician

Luz Minerva Burgos Fuster, M.D.

According to 2025 Medicare claims, Luz Fuster, M.D. (NPI: 1285667204) practices medical oncology in the Birmingham, AL market, with the plurality of this provider's patient population coming from Jefferson, AL. This provider's primary affiliated billing organization is BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (NPI: 1841216389; TIN: 522170293) and primary practice location at 35209-6889.

Fuster's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 186 traditional Medicare patients, billed 26,351 HCPCS/CPT codes, and received $299,390 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,149 prescription claims across 159 beneficiaries totaling $555,137 in drug costs, led by Eliquis (Apixaban). DME data shows 139 claims. Open Payments data shows 111 records totaling $2,349. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $565,183 to $299,390. Similarly, Part D prescription costs have fallen sharply in recent years, from $437,529 to $555,137. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,936 to $1,047.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	256	50,835	$565,183
2016	312	83,735	$1,099,494
2017	260	63,851	$963,301
2018	257	55,404	$865,212
2019	283	56,562	$847,440
2020	234	42,861	$808,385
2021	246	37,145	$708,065
2022	197	29,582	$494,300
2023	202	33,787	$336,257
2024	186	26,351	$299,390

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	120	861	$437,529
2016	171	1,185	$848,834
2017	164	1,430	$1,085,000
2018	148	1,262	$1,588,454
2019	160	1,110	$1,386,309
2020	153	1,141	$1,108,273
2021	147	1,116	$1,021,678
2022	160	1,089	$1,123,514
2023	174	1,125	$617,739
2024	159	1,149	$555,137

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	177	$28,737
2016	N/R	189	$24,180
2017	N/R	175	$6,370
2018	N/R	268	$19,950
2019	N/R	64	$2,150
2020	N/R	N/R	N/R
2021	N/R	33	$48,429
2022	N/R	48	$57,005
2023	N/R	49	$77,271
2024	N/R	139	$84,463

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	69	171	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	92	116	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	100	174	$12
36415	Insertion of needle into vein for collection of blood sample	159	375	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	159	387	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	66	2,130	$40,530
Venclexta	Venetoclax	11	308	$17,407
Exemestane	Exemestane	47	2,070	$7,746
Tamoxifen Citrate	Tamoxifen Citrate	110	6,120	$3,123
Letrozole	Letrozole	162	8,744	$2,874

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	12	$58,915
J1557	Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$22,563
J8521	Capecitabine, oral, 500 mg	N	N/R	26	$1,073
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	12	$923
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	27	$489

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	111	$2,349	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Luz Minerva Burgos Fuster, M.D.?

Tedicare shows public-source Medicare data for Luz Minerva Burgos Fuster, M.D. (NPI 1285667204), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Luz Minerva Burgos Fuster, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Luz Minerva Burgos Fuster, M.D.?

Luz Minerva Burgos Fuster, M.D. is linked to BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (billing NPI 1841216389) in the available physician profile data.

Does Luz Minerva Burgos Fuster, M.D. have Open Payments data?

Luz Minerva Burgos Fuster, M.D. has 111 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.